Humanized monoclonal anti-CD40 ligand (CD 154 antibody (Hu5c8) treatment inhibits the production of antiFVIII antibodies by SCID mice reconstituted with PBMC of a severe haemophilic patient with inhibitor
B. Vanzieleghem, Humanized monoclonal anti-CD40 ligand (CD 154 antibody (Hu5c8) treatment inhibits the production of antiFVIII antibodies by SCID mice reconstituted with PBMC of a severe haemophilic patient with inhibitor, HAEMOPHILIA, 6, 2000, pp. 25-25